-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
It's time for another dive into the biggest pre-market stock movers as we check out what's going on on Wednesday morning.
Moving shares this morning are clinical trial results, earnings, and prices of public stock offerings.
Let's get into that news below!
Pre-Market Stock Movers: 10 Top Gainers
- Atlis Motor Vehicles (NASDAQ:AMV) stock is rocketing more than 186% as it rallies following its initial public offering (IPO).
- SILO Pharma (NASDAQ:SILO) shares are rising over 78% after uplisting to the Nasdaq Exchange.
- Prothena Corp (NASDAQ:PRTA) stock is soaring more than 64% alongside positive Alzheimer's drug data from a rival.
- Biogen (NASDAQ:BIIB) shares are gaining over 43% due to it being the rival that posted the Alzheimer's drug data.
- Acumen Pharmaceuticals (NASDAQ:ABOS) stock is surging more than 29% as it also joins in on the Alzheimer's drug rally.
- BiomX (NYSEMKT:PHGE) shares are climbing over 27% ahead of its delisting from the Tel Aviv Stock Exchange next week.
- MorphoSys (NASDAQ:MOR) stock is increasing more than 19% in pre-market trading on Wednesday.
- India Globalization Capital (NYSEMKT:IGC) shares are getting an almost 19% boost this morning.
- TCR2 Therapeutics (NASDAQ:TCRR) stock is jumping over 17% alongside the release of clinical trial results.
- Longeveron (NASDAQ:LGVN) shares are up more than 17% in Wednesday morning trading.
10 Top Losers
- Mind Medicine (NASDAQ:MNMD) stock is plummeting over 35% after pricing a public stock offering.
- iBio (NYSEMKT:IBIO) shares are diving close to 33% with the release of preliminary results for fiscal Q4.
- Nano Labs (NASDAQ:NA) stock is tumbling more than 21% after revealing the pricing of a public stock offering.
- Gamida Cell (NASDAQ:GMDA) shares are taking a nearly 21% beating as it also priced a public stock offering.
- Powerbridge Technologies (NASDAQ:PBTS) stock is falling over 13% after rallying yesterday on NFT news.
- Avenue Therapeutics (NASDAQ:ATXI) shares are dropping more than 13% after rallying on Tuesday.
- EZGO Technologies (NASDAQ:EZGO) stock is sliding over 13% on no clear news today.
- MFA Financial (NYSE:MFA) shares are slipping more than 10% following two S-3ASR filings yesterday.
- Siyata Mobile (NASDAQ:SYTA) stock is dipping over 10% today.
- 9 Meters Biopharma (NASDAQ:NMTR) shares close out our pre-market stock movers down more than 9% following a rally yesterday on clinical trial data.
On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
The post Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday appeared first on InvestorPlace.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
InvestorPlace-股票市场新闻、股票建议和交易提示
It's time for another dive into the biggest pre-market stock movers as we check out what's going on on Wednesday morning.
现在是另一个潜入最大的开盘前股票走势的时候了,我们来看看周三早上发生了什么。
Moving shares this morning are clinical trial results, earnings, and prices of public stock offerings.
今天上午的走势是临床试验结果、收益和公开发行股票的价格。
Let's get into that news below!
让我们来看看下面的新闻吧!
Pre-Market Stock Movers: 10 Top Gainers
盘前炒股:十大涨幅最大的股票
- Atlis Motor Vehicles (NASDAQ:AMV) stock is rocketing more than 186% as it rallies following its initial public offering (IPO).
- SILO Pharma (NASDAQ:SILO) shares are rising over 78% after uplisting to the Nasdaq Exchange.
- Prothena Corp (NASDAQ:PRTA) stock is soaring more than 64% alongside positive Alzheimer's drug data from a rival.
- Biogen (NASDAQ:BIIB) shares are gaining over 43% due to it being the rival that posted the Alzheimer's drug data.
- Acumen Pharmaceuticals (NASDAQ:ABOS) stock is surging more than 29% as it also joins in on the Alzheimer's drug rally.
- BiomX (NYSEMKT:PHGE) shares are climbing over 27% ahead of its delisting from the Tel Aviv Stock Exchange next week.
- MorphoSys (NASDAQ:MOR) stock is increasing more than 19% in pre-market trading on Wednesday.
- India Globalization Capital (NYSEMKT:IGC) shares are getting an almost 19% boost this morning.
- TCR2 Therapeutics (NASDAQ:TCRR) stock is jumping over 17% alongside the release of clinical trial results.
- Longeveron (NASDAQ:LGVN) shares are up more than 17% in Wednesday morning trading.
- 阿特里斯机动车辆(纳斯达克:AMV)股价在首次公开募股(IPO)后反弹,涨幅超过186%。
- 思洛制药(纳斯达克:竖井)在纳斯达克交易所上市后,股价上涨了78%以上。
- 普罗塞纳公司(纳斯达克:PRTA)股价飙升超过64%,同时竞争对手的阿尔茨海默氏症药物数据也呈阳性。
- 生物遗传研究(纳斯达克:BIIB)股价上涨超过43%,因为它是发布阿尔茨海默氏症药物数据的竞争对手。
- Acumen制药公司(纳斯达克:ABOS)股价飙升超过29%,因为它也加入了阿尔茨海默氏症药物的反弹。
- BiomX(纽约时报:PHGE)股价在退市前攀升了27%以上特拉维夫证券交易所下周。
- 睡眠症(纳斯达克:更多)周三盘前交易中,股价涨幅超过19%。
- 印度全球化资本(纽约时报:IGC)今天上午,股价上涨了近19%。
- TCR2治疗公司(纳斯达克:TCRR)随着临床试验结果的公布,股价跃升了17%以上。
- 龙威龙(纳斯达克:LGVN)股价在周三早盘交易中上涨逾17%。
10 Top Losers
十大失败者
- Mind Medicine (NASDAQ:MNMD) stock is plummeting over 35% after pricing a public stock offering.
- iBio (NYSEMKT:IBIO) shares are diving close to 33% with the release of preliminary results for fiscal Q4.
- Nano Labs (NASDAQ:NA) stock is tumbling more than 21% after revealing the pricing of a public stock offering.
- Gamida Cell (NASDAQ:GMDA) shares are taking a nearly 21% beating as it also priced a public stock offering.
- Powerbridge Technologies (NASDAQ:PBTS) stock is falling over 13% after rallying yesterday on NFT news.
- Avenue Therapeutics (NASDAQ:ATXI) shares are dropping more than 13% after rallying on Tuesday.
- EZGO Technologies (NASDAQ:EZGO) stock is sliding over 13% on no clear news today.
- MFA Financial (NYSE:MFA) shares are slipping more than 10% following two S-3ASR filings yesterday.
- Siyata Mobile (NASDAQ:SYTA) stock is dipping over 10% today.
- 9 Meters Biopharma (NASDAQ:NMTR) shares close out our pre-market stock movers down more than 9% following a rally yesterday on clinical trial data.
- 精神医学(纳斯达克:MNMD)在为公开募股定价后,股价暴跌超过35%。
- IBio(纽约时报:IBio)随着第四财季初步业绩的发布,股价暴跌近33%。
- 纳米实验室(纳斯达克:北美)在披露公开发行股票的定价后,股价暴跌超过21%。
- 伽米达细胞(纳斯达克:GMDA)股价下跌近21%,因为该公司还为公开募股定价。
- 宏桥高科(纳斯达克:PBTS)股价在昨天NFT的消息中反弹后,目前跌幅超过13%。
- 大道治疗公司(纳斯达克:ATXI)股价在周二反弹后下跌超过13%。
- 易电行(纳斯达克:EZGO)股价在今天没有明确消息的情况下下滑超过13%。
- MFA金融(纽约证券交易所:MFA在S-3ASR昨日提交两份申请文件后,其股价下跌超过10%。
- Siyata Mobile(纳斯达克:SYTA)股票今天下跌了10%以上。
- 9米Biophma(纳斯达克:NMTR)股价收盘前下跌超过9%,此前我们的临床试验数据昨天出现反弹。
On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
在出版日期,威廉·怀特他没有(直接或间接)持有本文所述证券的任何头寸。本文表达的观点是作者的观点,以InvestorPlace.com为准。出版指南。
The post Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday appeared first on InvestorPlace.
周三,《今日最大的盘前股票交易者:10大赢家和输家》一文出现在InvestorPlace的首位。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧